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Preterm neonates supported by invasive intermittent mechanical 
ventilation (IMV) often experience poor postnatal growth characterized by feeding 
intolerance and failure to thrive.  One consequence of poor postnatal nutrition is 
reduced substrate availability such as essential fatty acids, and reduced alveolar 
formation, all resulting in poor lung outcomes and risk for chronic lung disease.   
Our group showed that preterm lambs supported by IMV have feeding 
intolerance, poor growth, and impaired alveolar formation.  In contrast, preterm 
lambs supported by high-frequency nasal ventilation (HFNV) feed and grow, and 
have normal alveolar formation.  When preterm lambs supported by HFNV have 
feeding volumes restricted, they experience poor postnatal growth, and have 
arrested alveolar formation.  One pathway involved in alveolar formation is the 
essential fatty acid docosahexanoic acid (DHA) activated PPARγ-Setd8-
H4K20me1-Wnt pathway. 
We hypothesized that restricted feeding of preterm lambs supported by 
HFNV reduces available serum DHA, as well as components of the PPARγ-
Setd8-H4K20me1-Wnt pathway. 
To test this hypothesis, we used the preterm lamb model of chronic lung 
disease.  Two groups of preterm lambs were supported by noninvasive HFNV for 
21 days.  One group (restricted) had feedings restricted to 75% (mL/kg/day) of 
that received by the control group (matched for feeding tolerated during IMV).
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  The other group (control) received feedings as tolerated, progressing to ad 
libitum. Both groups were fed ewe’s colostrum for three days, proceeding to 
mature ewe milk.  We measured plasma and lung DHA, as well as components 
of the PPARγ-Setd8-H4K20me1-Wnt pathway. 
Restricted feeding of preterm lambs reduced serum and lung DHA levels 
relative to control.  Restricted feeding of preterm lambs also significantly 
decreased lung PPARγ, Setd8, and Wnt signaling components β-catenin, and 
Wnt11 compared to control.  Restricted feeding also reduced Wnt output gene 
MMP9 mRNA transcript level compared to control.   
In conclusion, restricted feeding of preterm lambs managed by HFNV 
reduces serum DHA and components of the PPARγ-Setd8-H4K20me1-Wnt 
pathway in the lung.  We speculate that restoration of serum DHA levels in 
preterm lambs managed by restricted feeding during HFNV will restore PPARγ-
Setd8-H4K20me1-Wnt pathway activation and alveolar formation. 
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Preterm neonates often require respiratory support with invasive 
mechanical ventilation (IMV) after birth, increasing the risk for the development of 
bronchopulmonary dysplasia (BPD), the chronic lung disease of infancy.  BPD is 
characterized by alveolar simplification and decreased respiratory function (1-3).  
Even with advances in management of preterm birth, BPD remains a significant 
problem with 5,000 to 10,000 new cases each year in the United States.   
Development of BPD is multifactorial, with mode of ventilation and feeding 
intolerance as known contributors.  BPD often develops following oxygen 
supplementation via IMV. However, decreased incidences of BPD are seen with 
noninvasive, nasal continuous positive airway pressure (nCPAP) type ventilation 
(2, 4, 5).  Preterm infants managed on IMV commonly experience poor postnatal 
growth and restricted nutrition (6, 7).  
Clinical studies of premature human infants show that poor fetal growth is 
a predictor of chronic lung disease (6, 8-10).  Common clinical management such 
as the slow initiation of enteral feedings and parenteral nutrition contribute to 
poor growth in the preterm infant (5, 11, 12).  Improper development of the gut, 
secondary to prematurity, also contributes to feeding intolerance and restricted 
nutrition to the neonate.  All of these issues contribute to poor postnatal growth 
and inadequate nutrition, factors which place the preterm infant at greater risk for 
developing BPD (5).  
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Animal models have confirmed the role of restricted nutrition and the 
development of BPD (2, 13).  The large animal, clinically relevant, preterm lamb 
model of chronic lung disease provides an opportunity to test the role of limited 
nutrition to the neonate (2).  Using the preterm lamb model of chronic lung 
disease, historical studies from our lab showed differences in lung outcomes and 
feeding tolerance between IMV and noninvasive, high-frequency nasal ventilation 
(HFNV), a type of ventilation similar to nCPAP ventilation.  Preterm lambs 
managed by IMV had feeding intolerance, poor growth, and poor lung outcomes 
compared to preterm lambs managed by HFNV (14).  Lung histology in lambs 
managed by IMV showed alveolar simplification, characterized by thick 
mesenchymal walls, short, thick, secondary septa, and decreased apoptosis 
(Figure 1) (14).  Lung histology in lambs managed by HFNV display normal 
alveolar formation.  The results of this study indicate an interplay between mode 
of ventilation and nutrition.  
 
 
 Figure 1 IMV vs. HFNV ventilation type with lung and growth outcomes  	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To evaluate the role of nutrition in lung outcomes of preterm lambs, our 
lab conducted a second study with two groups of preterm lambs both managed 
by HFNV.  One group of preterm lambs had feeding volumes restricted to match 
the feeding intolerance exhibited by the historical IMV managed lambs (restricted 
feeding group); this included milk feedings of ~75% of the control group milk 
volume.  The control group consumed milk as tolerated (Figure 2).  The results 
showed the restricted feeding group consumed significantly less and grew less 
than the control group. 
The lung histology of the control group showed normal lung development.   
In contrast, the restricted feeding group had thick mesenchymal walls, and short 
secondary septa, indicative of poor alveolar formation (Figure 3).   
While nutrition appears to affect lung alveolar formation, the mechanism 
remains unknown.  One major molecular pathway involved in alveolar formation 
is the PPARγ-Setd8-H4K20me1-Wnt signaling pathway (15, 16). 
 
 








Figure 3 Histopathology for HFNV restricted feeding and control 
 
 
At the initiation of the pathway is peroxisome proliferator receptor gamma 
(PPARγ).  PPARγ is a member of the nuclear receptor family of transcription 
factors.  Ligand activation of PPARγ results in the transcription of the chromatin-
modifying enzyme Setd8 (17).  Setd8 is the primary mechanism for the 
monomethylation of histone 4 (H4K20me1), which is an epigenetic modification 
(17, 18).  In order for Wnt signaling to occur, the H4K20me1 epigenetic mark 
must be in place (18).  Briefly, in Wnt signaling, Wnt components such as Wnt11 
and Wnt7a are activated, which allows for the accumulation of β-catenin in the 
cytoplasm.  β-catenin translocates to the nucleus, and acts as a transcription 
factor for gene enhancers in the TCF/LEF family.  LEF1 activation results in the 
transcription of genes integral in lung structural development, such as matrix 
metallopeptidase 7 and 9 (MMP7 and MMP9) (19).  The final transcription of Wnt 
signaling output genes such as MMP9 promotes proper lung and alveolar 
formation (Figure 4). 
 




Figure 4 The PPARγ-Setd8-H4K20me1-Wnt signaling pathway 
 
 
One ligand with a high binding affinity for PPARγ is the essential omega-3 
polyunsaturated fatty acid docosahexanoic acid (DHA) (16, 20-22).  DHA is of 
special interest nutritionally for preterm infants, as it must be obtained via the 
placenta during the final trimester, a period of gestation often missed due to 
preterm birth (12, 23, 24).  DHA is also physiologically relevant in chronic lung 
disease.  Specifically, infants who develop lung disease have decreased serum 
levels of DHA (12, 25).  The effect of restricted nutrition on DHA status and the 
PPARγ pathway activation in the lung of preterm lambs is unknown.  
We hypothesized that restricted feeding in preterm lambs managed by 
HFNV will lead to decreased serum DHA.  We further hypothesized that 
restricted feeding will decrease flux through the PPARγ-Setd8-H4K20me1-Wnt 
signaling pathway, contributing to the previously observed poor lung outcomes. 





 We used a well-established, IACUC (#11-11002) approved, preterm lamb 
model in accordance with guidelines of the University of Utah Animal Care 
Committee.  Briefly, pregnant ewes were given antenatal steroids 36 hours 
before delivery.  Lambs were surgically delivered preterm at about 131 days 
gestation, where term is 150 days.  Immediately following birth, lambs were 
intubated and treated with surfactant and caffeine citrate.  All lambs were 
intubated with intermittent mandatory ventilation for three hours to ensure proper, 
initial oxygenation.  After three hours, the lambs were extubated and placed on 
high-frequency nasal ventilation for the remainder of the study.  Once on HFNV, 
lambs were placed in one of two groups: either the restricted feeding group or 
control group. 
All lambs were given colostrum for the first three days of life, and mature 
ewe milk for the remainder of the study with Sav-A-Lamb® milk replacer.  
Feedings were initially given via orogastric tube as lambs were weaned from IMV 
to HFNV.  Bottle feedings were given when tolerated, and continued through the 
completion of the study.  Feedings were provided and recorded every two hours.   
Restricted feeding lambs had their volumes reduced to match volumes 
tolerated by historical IMV lambs in mL/kg/day, whereas control lambs were fed 
ad libitum.  Preterm lambs in both groups were maintained with respiratory gas 
parameters within physiological ranges.  Both groups of preterm lambs were
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managed by HFNV for 21 days.  After 21 days, lambs were terminated, with 




Plasma and lung fatty acids were quantified using mass spectrometry by 
Dr. Camilia Martin’s laboratory in Harvard, Massachusetts. Data are expressed in 




Western blots were used to measure protein abundance of PPARγ, Setd8, 
and β-catenin with techniques previously described by our lab (16, 26).  Briefly, 
total protein was isolated by homogenizing lung tissue in RIPA buffer and 
protease inhibitor (PI) cocktail (Roche-Complete Mini). Samples were 
centrifuged, and stored at – 80°C until use.  Protein abundance was quantified 
using the Pierce BCA protein assay kit (ThermoScientific) and was stored at -
80°C until use.   
Total (30 ug) protein was loaded and separated on Nu-PAGE 10% Bis-
Tris Midi Gels (Novex by Life Technologies). Proteins were transferred to PVDF 
membranes (Milli-pore).  The antibodies used were PPARγ (DB134, Delta 
Biolabs), Setd8 (GTX119440, GeneTex), and β-catenin (Cell Signaling 9582).  
Antibodies were detected with Western Lightning enhanced chemiluminescence 
and quantified using an Image Station 2000R (Eastman Kodak). 
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Quantitative Real-time RT-PCR 
 
Quantitative real-time reverse transcriptase polymerase chain reaction 
(real-time RT-PCR) was used to measure mRNA levels of Wnt signaling 
components.  An initial RNA-seq performed by our lab revealed differences 
between Wnt11 and MMP9 gene expression between restricted feeding and 
control lambs; as a result, we chose to quantify expression of these genes in this 
study.  
RNA was extracted from lung tissue samples using an RNeasy Mini Kit 
(Qiagen).  cDNA was generated using a High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems).   
The Life Technologies Assay-on demand primer/probe sets used for 
Wnt11 were (Bt03255381_m1).  Custom designed primer and probe sequences 
were used for MMP9 (see Appendix).  GAPDH was used as an internal control.  
Data and RT-PCR amplification were analyzed by QuantiStudio 12K Flex Real 
Time PCR system, with mRNA levels determined consistent with the comparative 




Data are presented as mean ± standard deviation.  Measurements of 
plasma DHA used an n=3 for each group.  At the time of the study, only n=1 
sample was available for lung DHA measurement, and therefore, statistical 
analysis was not applied. For PPARγ, Setd8, β-catenin, Wnt11, and MMP9, 
means were compared using nonparametric Mann-Whitney U test; n=3-4 
samples per group.  Statistical significance was accepted at p ≤ 0.05.





Effects of Restricted Feeding on Plasma Docosahexanoic Acid 	  
Preliminary plasma and lung DHA abundance was quantified in the 
restricted feeding and control groups of preterm lambs managed by HFNV.  For 
plasma DHA, lambs in the restricted feeding group had a nonsignificant reduction 
in plasma DHA compared to control lambs (p=0.06, n=3) (Figure 5).  For lung 
DHA levels, the restricted feeding group also had reduced DHA in lung compared 
to control lambs (Figure 6).  However, no statistical analysis could be applied due 
to an n=1 in the restricted feeding group.  
 
 
Figure 5 Plasma DHA %mol relative to total fatty acids
 




Figure 6 Lung DHA %mol relative to total fatty acids 
	  
The PPARγ-Setd8-H4K20me1-Wnt Signaling Pathway 	  
Components of the PPARγ-Setd8-H4K20me1-Wnt signaling pathway were 
measured.  Protein abundance of PPARγ, Setd8, and β-catenin was quantified 
from lung tissue.  The restricted feeding group had significantly less PPARγ 
protein abundance in the lung compared to the control group (p<0.05) (Figure 7).  
Protein abundance of Setd8 was significantly reduced in the restricted feeding 
group compared to controls (p<0.05) (Figure 8).  Wnt signaling component β-
catenin was also significantly reduced in the restricted feeding group compared 
to control (p<0.05) (Figure 9).  For Wnt signaling component Wnt11, mRNA were 
quantified and compared between groups.  The restricted feeding group had 
significantly less Wnt11 mRNA abundance (p=0.03) compared to the control 
(Figure 10). 
Lung mRNA levels of Wnt signaling output gene MMP9 were also 
measured.  MMP9 mRNA in the restricted feeding group was trending towards 
reduction compared to control; however, it was not statistically significant 
(p=0.22) (Figure 11). 
  




Figure 7  PPARγ protein abundance 




Figure 8  Setd8 protein abundance 




Figure 9  β-catenin protein abundance 
*Denotes statistical significance relative to control, p ≤ 0.05 
 




Figure 10  Wnt11 mRNA abundance 











The results of our study show the impact of nutrition on a molecular 
mechanism of lung development.  An overall restriction of feeding of preterm 
lambs led to reduced flux through components of the PPARγ-Setd8-H4K20me1-
Wnt signaling pathway.  Despite limited samples, our preliminary data imply that 
plasma and lung DHA levels may also be reduced by restricted feeding in 
preterm lambs managed by HFNV.  Together, our results suggest a novel 
mechanism for alveolar simplification in restricted feeding of preterm lambs 
managed by HFNV.   
 DHA is an important essential fatty acid, with disturbances implicated in 
both preterm birth and altered lung development.  Our results suggest that 
restricted feeding leads to decreased plasma DHA and possibly reduced lung 
DHA.  These findings support research that restricted feeding secondary to 
prematurity is linked to marked differences in available essential fatty acids (12, 
25).  
Research on DHA and lung outcomes shows that DHA supplementation is 
linked to improved lung outcomes (28).  Enteral formulas for preterm infants are 
supplemented with DHA, but not at the level required to replete low stores of 
DHA after preterm birth (12).  Normal breast milk also does not contain adequate 
DHA to replete stores for the preterm infant.  However, maternal supplementation
 of DHA in breast-fed premature infants improved lung outcomes (12). 
   
 
14 
Parenteral nutrition, while not explored in our study, is linked specifically to 
the development of chronic lung disease likely due to its lipid emulsion lacking in 
DHA (12).  Clinical studies with preterm infants receiving parenteral nutrition 
using lipid emulsions containing fish oil (DHA) showed less incidence of chronic 
lung disease (29).  Our findings of reduced plasma DHA support the notion that 
DHA may be a key component in arrested lung development in preterm infants. 
As plasma DHA is a ligand and activator of PPARγ, limited DHA 
availability is likely to be linked to decreased activation of the PPARγ-Setd8-
H4K20me1-Wnt signaling pathway in the lung (21, 22).  While unable to make 
definitive conclusions based on our sample size, our data strongly suggest that 
decreased DHA in conditions of restricted feeding may contribute to less 
activation of PPARγ in conditions of restricted feeding.  
Limited activity of PPARγ results in decreased activity of its downstream 
targets such as the enzyme Setd8 (17).  We found that PPARγ and Setd8 protein 
abundance was reduced in lung tissue under conditions of restricted feeding, 
suggesting reduced PPARγ protein leads to reduced Setd8 protein.  Decreased 
PPARγ and Setd8 protein abundance in conditions of restricted feeding support 
previous research from our lab in the rat, and support the role of limited DHA in 
impaired alveolarization (16).   
Decreased abundance of Setd8 may hold implications for the proper 
activation of Wnt signaling.  The major role of Setd8 is to place the epigenetic 
mark (H4K20me1) on histone 4.  With reduced Setd8, we expect to see 
differences in genome-wide methylation of histone 4.  The epigenetic 
monomethylation of histone 4 (H4K20me1) mediates the activation of Wnt 
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signaling (18).   
Wnt signaling is known to be integral and active during lung development 
(15).  We found that Wnt11 and β-catenin were decreased in conditions of 
restricted feeding, suggesting impaired Wnt signaling.  A decrease in 
components of Wnt signaling in preterm lambs with restricted feeding is 
consistent with our previous observations of altered alveolar formation, as Wnt 
signaling output genes are linked to lung development (15).  For example, Wnt11 
is critical for lung mesenchymal formation (30).  Wnt signaling components, such 
as Wnt11, lead to accumulation of β-catenin in the cytoplasm (19).  β-catenin is 
integral in promoting Wnt signaling (15). 
Proper accumulation of β-catenin allows initiation of other pathways 
leading to transcription of Wnt signaling output genes (15).  The output genes of 
Wnt signaling such as the matrix metalloproteinases (MMPs) are involved in 
structural formation of lung tissue (15, 31).  We found that restricting feeding led 
to decreased mRNA abundance of MMP9.  Decreased MMP9 has been shown 
to be involved with impaired alveolarization (32, 33).  Therefore, reduced MMP9 
may be one mechanism by which conditions of restricted feeding contribute to 
previously observed structural differences in alveolarization. 
Our study is not without limitations.  Each lamb in our model requires 
constant 24-hour supervision and management, driving the cost of the 
experiment high, and the sample size low.  Comorbidities of preterm birth are 
common in the preterm lamb model, similar to preterm human infants, making 
consistent sample collection difficult.  Our study demonstrated the association 
between available DHA and the PPARγ-Setd8-H4K20me1-Wnt signaling 
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pathway.  However, we did not demonstrate a cause-and-effect relationship. 
Future studies isolating the connection between available DHA and its role as a 
ligand in PPARγ activation are warranted.  Currently, we are conducting studies 
using DHA supplementation in conditions of restricted feeding with the goal of 
normalizing plasma DHA levels to those of term lambs, and correcting arrested 
alveolarization.  We are also conducting studies to determine the effect of PPARγ 
antagonists in conditions of ad libitum feeding and the downstream effects on the 
PPARγ-Setd8-H4K20me1-Wnt signaling pathway. 
A further limitation of our study is that we did not measure levels of 
H4K20me1 in the lung of our study lambs. We are currently conducting ChiP-
sequencing in order to determine genome-wide differences in methylation of 
histone 4 (H4K20me1).  Results of the ChiP-sequencing will demonstrate the 
effects of reduced Setd8 on overall H4K20me1, and may indicate which regions 
of the genome may contribute to lung development.  
  




In conclusion, restricted feeding of preterm lambs reduces available serum 
and lung DHA, and may be linked to decreased activation of PPARγ.  Restricted 
feeding of preterm lambs also reduced flux through components of the PPARγ-
Setd8-H4K20me1-Wnt signaling pathway.  Our results support an important role 
of nutrition and one molecular pathway integral in lung development.





Table 1 Primer/Probe Sequences for MMP9 and GAPDH 
GENE SEQUENCE 
MMP9 Forward: GTGGCACCATCACAACATCAC 
 Reverse: CGCGCGGCAGGTCTT 
 Probe: TACTGGATCCAAAATTACTC 
GAPDH Forward: CAAGATGGTGAAGGTCGGTGT 
 Reverse: CAAGAGAAGGCAGCCCTGG 
 Probe: GCGTCCGATACGGCCAAATCCG 
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